SEVEN YEAR

CONSOLIDATED INCOME STATEMENTS

 

R million 2007  2006  2005  2004  2003  2002  2001 
Profit before taking into account              
     the following 1 476  1 476  1 384  1 292  1 209  734  504 
Impairments, capital and              
     non-recurring items 51  3 165  2 216  (132) 1 055  (158) 1 523 
Consolidated profit before tax 1 527  5 103  3 600  1 160  2 264  576  2 027 
Taxation (403) (857) (417) (397) (394) (173) (109)
Consolidated profit after tax 1 124  4 246  3 183  763  1 870  403  1 918 
Share in after-tax profit of              
     associated companies 6 003  4 354  5 742  3 177  7 262  3 255  4 765 
Profit before taking into              
     account the following 5 995  4 428  4 514  4 164  4 421  3 881  2 901 
Impairments, capital and     `        
     non-recurring items 8  (74) 1 228  (987) 2 841  (626) 1 864 
               
Net profit after tax 7 127  8 600  8 925  3 940  9 132  3 658  6 683 
Minority interest (185) (398) (407) (335) (446) (151) (109)
Attributable net profit for the year 6 942  8 202  8 518  3 605  8 686  3 507  6 574 
Headline earnings 6 853  5 084  4 998  4 687  4 856  4 252  3 195 
Headline earnings per share (cents) 1 445.4  1 052.3  1 005.0  931.3  940.1  814.5  612.1 
Headline earnings per share –              
     excluding non-recurring              
     portion of BEE costs (cents) 1 445.4  1 130.9  1 005.0  931.3  940.1  814.5  612.1 
Earnings per share (cents) 1 464.2  1 697.6  1 712.9  716.3  1 681.6  671.8  1 259.4 
Dividends per share (cents)              
– Ordinary 434.00  361.00  314.00  285.00  248.00 206.00  162.00 
– Special   400.00  600.00  200.00    100.00    
               

The figures for 2005 above have been restated in terms of IFRS. Figures for the years before 2005 have not been adjusted.

Since 1 January 2006, Medi-Clinic has been accounted for as an associated company, while it was consolidated previously.

Remgro’s relative share performance (based to 100)

 

R million 2007  2006  2005  2004  2003  2002  2001 
BALANCE SHEETS              
Property, plant and equipment 2 565  2 444  4 120  3 515  3 253  2 083  2 027 
Investments – Associated companies 33 033  26 098  28 201  22 737  19 844  16 984  13 164 
Other non-current assets 6 797  4 584  2 645  2 106  3 607  2 831  2 968 
Current assets 7 466  8 210  4 773  5 372  4 079  4 435  3 395 
Total assets 49 861  41 336  39 739  33 730  30 783  26 333  21 554 
Total equity 46 427  38 090  36 844  31 411  28 981  24 991  20 177 
Non-current liabilities 1 580  1 144  866  685  472  244  310 
Current liabilities 1 854  2 102  2 029  1 634  1 330  1 098  1 067 
Total equity and liabilities 49 861  41 336   39 739  33 730  30 783  26 333  21 554 
Net asset value per share (Rand)              
(attributable to own members)              
– at book value 96.69  78.14  71.51  59.26  54.19  46.10  37.14 
– at intrinsic value 221.00  157.59  119.97  100.36  77.23  89.50  64.32 
               
CASH FLOW STATEMENTS              
Cash generated from operations 1 666  1 474  1 566  1 383  1 055  618  401 
Cash flow generated from returns              
   on investments 3 040  4 200  2 670  2 013  2 542  1 697  1 196 
Taxation paid (676) (369) (546) (363) (220) (111) (116)
Cash available from operating activities 4 030  5 305  3 690  3 033  3 377  2 204  1 481 
Dividends paid (3 813) (4 676) (2 642) (1 438) (1 765) (968) (303)
Cash flow from operating activities 217  629  1 048  1 595  1 612  1 236  1 178 
Net investing activities (1 725) 3 364  (2 203) (528) (1 943) (201) 356 
Net financing activities 70  99  9  62  (82) (158) (631)
Net increase/(decrease) in cash              
    and cash equivalents (1 438) 4 092  (1 146) 1 129  (413) 877  903 
               

The figures for 2005 above have been restated in terms of IFRS. Figures for the years before 2005 have not been adjusted. Since 1 January 2006, Medi-Clinic has been accounted for as an associated company, while it was consolidated previously.

Since 1 January 2006, Medi-Clinic has been accounted for as an associated company, while it was consolidated previously.

Cash movement at the holding company (“cash at the centre”) (R million)